Shantibhusan Senapati

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Debasish Mohapatra · 5 shared papers, 2019–2023 · strength 0.82
   • Paper ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells. DOI 10.1016/j.bbrc.2022.10.021↗
   • Paper MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. DOI 10.1016/j.lfs.2022.120592↗
   • Paper Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with… DOI 10.1007/s00262-023-03562-9↗
2. Biswajit Das · 4 shared papers, 2018–2022 · strength 0.64
   • Paper Functional and mechanistic studies reveal MAGEA3 as a pro-survival factor in pancreatic cancer cells. DOI 10.1186/s13046-019-1272-2↗
   • Paper MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. DOI 10.1016/j.lfs.2022.120592↗
   • Paper Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced … DOI 10.1038/s41374-021-00690-7↗
3. Voddu Suresh · 4 shared papers, 2018–2026 · strength 0.63
   • Paper Probiotics Mitigate High-cholesterol Diet-driven Fatty Liver and Pancreatic Cancer by Restoring Macrophage Homeostasis. DOI 10.1016/j.jcmgh.2025.101644↗
   • Paper Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced … DOI 10.1038/s41374-021-00690-7↗
   • Paper Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human … DOI 10.1038/s41598-019-51947-7↗
4. Deepti Parida · 3 shared papers, 2022–2026 · strength 0.61
   • Paper Probiotics Mitigate High-cholesterol Diet-driven Fatty Liver and Pancreatic Cancer by Restoring Macrophage Homeostasis. DOI 10.1016/j.jcmgh.2025.101644↗
   • Paper Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with… DOI 10.1007/s00262-023-03562-9↗
   • Paper Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced … DOI 10.1038/s41374-021-00690-7↗
5. Madhuri Dutta · 3 shared papers, 2022–2023 · strength 0.57
   • Paper ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells. DOI 10.1016/j.bbrc.2022.10.021↗
   • Paper MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. DOI 10.1016/j.lfs.2022.120592↗
   • Paper Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with… DOI 10.1007/s00262-023-03562-9↗
6. Anasuya Roychowdhury · 2 shared papers, 2022 · strength 0.39
   • Paper ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells. DOI 10.1016/j.bbrc.2022.10.021↗
   • Paper MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2. DOI 10.1016/j.lfs.2022.120592↗
7. Mir Mohd Faheem · 3 shared papers, 2018–2021 · strength 0.35
   • Paper Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer… DOI 10.1016/j.tranon.2020.100879↗
   • Paper Corrigendum to 'Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of p… DOI 10.1016/j.tranon.2021.101136↗
   • Paper Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancr… DOI 10.1002/mc.22828↗
8. Archana Katoch · 3 shared papers, 2018–2021 · strength 0.35
   • Paper Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer… DOI 10.1016/j.tranon.2020.100879↗
   • Paper Corrigendum to 'Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of p… DOI 10.1016/j.tranon.2021.101136↗
   • Paper Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancr… DOI 10.1002/mc.22828↗
9. Anindya Goswami · 3 shared papers, 2018–2021 · strength 0.35
   • Paper Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer… DOI 10.1016/j.tranon.2020.100879↗
   • Paper Corrigendum to 'Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of p… DOI 10.1016/j.tranon.2021.101136↗
   • Paper Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancr… DOI 10.1002/mc.22828↗
10. Aliva Prity Minz · 2 shared papers, 2022–2023 · strength 0.33
    • Paper Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with… DOI 10.1007/s00262-023-03562-9↗
    • Paper Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced … DOI 10.1038/s41374-021-00690-7↗
11. Sujit Suklabaidya · 2 shared papers, 2018 · strength 0.17
    • Paper Experimental models of pancreatic cancer desmoplasia. DOI 10.1038/labinvest.2017.127↗
    • Paper Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancr… DOI 10.1002/mc.22828↗
12. Surinder K. Batra · 3 shared papers, 2011–2012 · strength 0.10
    • Paper Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. DOI 10.1038/onc.2011.505↗
    • Paper Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic canc… DOI 10.1158/1078-0432.ccr-10-1937↗
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗
13. Debasis Nayak · 1 shared paper, 2018 · strength 0.07
    • Paper Dual role of Par-4 in abrogation of EMT and switching on Mesenchymal to Epithelial Transition (MET) in metastatic pancr… DOI 10.1002/mc.22828↗
14. Navneet Momi · 1 shared paper, 2012 · strength 0.04
    • Paper Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells. DOI 10.1038/onc.2011.505↗
15. Subhankar Chakraborty · 1 shared paper, 2011 · strength 0.03
    • Paper Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic canc… DOI 10.1158/1078-0432.ccr-10-1937↗
16. Lynette M. Smith · 1 shared paper, 2011 · strength 0.03
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗
17. Maneesh Jain · 1 shared paper, 2011 · strength 0.03
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗
18. Moorthy Palanimuthu Ponnusamy · 1 shared paper, 2011 · strength 0.03
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗
19. Sushil Kumar K · 1 shared paper, 2011 · strength 0.03
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗
20. Satyanarayana Rachagani · 1 shared paper, 2011 · strength 0.03
    • Paper Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadher… DOI 10.1038/bjc.2011.31↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.